Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations - Concepedia

Concepedia

Publication | Closed Access

Efficacy of afatinib or osimertinib plus cetuximab combination therapy for non-small-cell lung cancer with EGFR exon 20 insertion mutations

50

Citations

23

References

2018

Year

Hanako Hasegawa, Hiroyuki Yasuda, Junko Hamamoto, Keita Masuzawa, Tetsuo Tani, Shigenari Nukaga, Toshiyuki Hirano, Keigo Kobayashi, Tadashi Manabe, Hideki Terai,

Insertion MutationsCetuximab Combination TherapyNon-small-cell Lung CancerMedicinePathologyBronchial NeoplasmCancer TreatmentCancer GeneticsOncologyRadiation OncologyLung Cancer

References

	Year	Citations

Page 1

Page 1